or a coronary vessel spasm. Chest pain (angina pectoris) results when the blood supply to the heart muscle is temporarily reduced (Arnot Ogden Medical Center, 1998) . The most severe outcome for coronary artery disease is myocardial infarction-death of the heart tissue (Bouma. 1999) .
Approximately 960,000 Americans die each year as a result of cardiovascular disease (Community Health Charit ies of Connecticut, 2002) . Deaths from coronary artery disease and stroke accounted for 45.2 % of all deaths in women (Center for Disease Control & Prevention, 2000b) . Lifetime risk at age 40 is one in two for men, and one in three for women (Lloyd-Jones, 1999) . At least 50 million Americans have some form of cardiovascular disease. Almost 6 million hospitalizations each year are caused by cardiovascular disease (Healing With Nutrition , 2002) . Ten million disabilities are reported annually by Americans aged 65 and older (Healing With Nutrition, 2002) .
In 1999, the cost of cardiovascular disease in the United States was estimated to be $286 .5 billionincluding the cost of health expenditures and lost producti vity from illness and death (Center for Disease Control & Prevention, 2000a ) . Reduced productivity was reported eight times more frequently by workers younger than 55 years old with heart disease. Lost wages caused by health related absenteei sm could cost as much as $65 billion annu ally in the United State s (Martin, 2001) .
LITERATURE REVIEW
The literature review consists of several studies identifying specific issues pertinent to women 's cardiovascu-lar health and mortality. Gender differences in risk factors, presentation, and management of coronary artery disease are noted. These issues may contribute to the slow decline of women's cardiovascular mortality rate. By identifying and understanding these issues, occupational health professionals can provide specific health information to women.
Risk Factors
Several gender differences have been identified in clients with unstable angina. Women tend to have more comorbid diseases, such as diabetes and congestive heart failure, when presenting with cardiovascular complaints (Scirica, 1999; Vaccarino, 1999) . This may be explained, in part, by the increased age of women with coronary artery disease. These disease processes can ultimately affect the woman's mortality-especially when combined with heart disease.
Diabetes is an extremely important factor to note in a woman's cardiovascular assessment. Women with diabetes experience abnormalities in platelet function and alterations in lipoproteins and vascular epithelium, which can promote coronary artery disease. These processes are believed to block the beneficial effects of estrogen on the heart (Sowers, 1998) . Thus, diabetes removes the gender differences in the prevalence of heart disease (Sowers, 1998) .
The risk of death from coronary artery disease in women increases after the onset of either natural or surgical menopause (Finking, 1999) . The role of estrogen and progesterone are not completely understood in relation to primary and secondary prevention of coronary artery disease (Mosca, 2001) . Despite earlier findings, women with cardiovascular disease may not be candidates for hormone replacement therapy (Alexander, 2001) .
Women who have had both ovaries removed (i.e., bilateral oophorectomy) may have less favorable consequences related to heart disease when compared with women who have had only their uterus removed (i.e., hysterectomy). The oophorectomized women, ages 50 to 89, exhibited higher lipoproteins and glucose than women who had not had oophorectomies or hysterectomies. These risk factors were not completely eliminated by estrogen use (Kritz-Silverstein, 1997) .
Psychosocial factors, such as low educational attainment and low socioeconomic status, are more strongly associated with an increased risk of cardiovascular morbidity and mortality in women when compared with men (Warnala, 1999) . Low educational levels are associated with psychosocial stress (e.g., high job stress, depression, little social support) and may lead to unhealthy lifestyle behavior and pathogenic physiological reactions. These factors, in tum, can lead to coronary artery disease.
Elderly women present a special risk when assessing for psychosocial stress because of social vulnerability. This is explained, in part, because elderly women often are widowed or living alone with physical disabilities. They are also more likely to live in poverty and lack adequate social support of family or friends (Center for Disease Control & Prevention, 2000c) .
Presentation
Women more often have atypical symptoms of cardiac distress (University of Pennsylvania Health System, 1997) . Women are less likely to exhibit typical symptoms of angina-the sudden pressure, fullness, or squeezing pain in the center of the chest. Symptoms for women include chest pain radiating to jaw or left arm, abdominal pain, shortness of breath, overwhelming fatigue, and unexplained lightheadedness (Pope, 2000) .
Pathophysiologic and anatomic differences, such as greater coagulation and reduced presence of collateral blood flow, may have accounted for under diagnosis and delay in treatment of coronary artery disease in women (Bouma, 1999; Sowers, 1998) . When compared to men, women are less likely to be diagnosed with an infarction with sinus tachycardia (ST) elevation, an ECG rhythm suggesting an occlusion in coronary arteries (Cohen, 2000; Hochman, 1999) .
Women have been found to have less severe coronary disease (i.e., less narrowing of coronary arteries) on angiography and to be less likely to have a positive exercise stress test (Scirica, 1999) . Because of the atypical presentation, women are less likely to be diagnosed with myocardial infarction on admission and wait longer than men before going to the hospital (Hochman, 1999; Scirica, 1999; Vaccarino, 1999) .
High density lipoprotein (HDL) cholesterol levels among women with coronary artery disease may not serve as protective factors against future coronary events (Bittner, 2000) . This finding suggests protective HDL levels may need to be redefined for women diagnosed with coronary artery disease. These risk factors indicate the need for careful assessment of women's health status and behaviors.
Maintenance
Research indicates gender differences are present in the maintenance of coronary artery disease and myocardial infarction. Less aggressive medical and surgical treatment for coronary artery disease in women has been noted (Gan, 2000; Scirica, 1999; Vaccarino, 1999) . The use of established treatment, such as aspirin and thrombolytic therapy, has been shown to be lower in women than in men (i.e., on admission and after discharge), despite similar use of antihypertensive and antianginal medications.
Women are referred to surgery later and less often than men. Some believe this factor may be beneficial for women because men undergo too many procedures which may increase mortality (Bittner, 2000) . Despite advances in intra-aorta balloon counterpulsation (IABC) and the use of fibrinolytic treatment, women are at a greater risk for complications, such as bleeding (Cohen, 2000; Hochman, 1999) . A weight adjusted regimen of heparin is recommended for women of low body weight to prevent such complications.
Literature Critique
The overall research designs of the aforementioned studies were strong with appropriate data collection methods and analysis testing. All nine studies were quantitative in nature. Seven studies were retrospective in design (Bit-tner, 2000; Gan, 2000; Hochman, 1999; Kritz-Silverstein, 1997; Scirica, 1999; Vaccarino, 1999; Wamala, 1999) , and two were prospective studies (Cohen, 2000; Pope, 2000) .
The information sources for these studies were medical records and client reports. Using these information sources can create a problem in defining exposure to risk factor recall bias in self reported behaviors. The accuracy of records, such as death certificates and underlying causes, creates concerns about reliability.
All the aforementioned studies were limited in some way. Cases of myocardial infarction were limited to clients admitted to the hospital (Cohen, 2000) or belonging to specific study registries (Hochman, 1999; Scirica, 1999; Vaccarino, 1999) . All measures may not accurately reflect an individual's response or risk. Individual variations in risk factors must be taken into account. When studying heart disease, there is an assumption that exposure to risks remain stable.
Knowledge Gaps
The misconception that heart disease is primarily a disease in men continues to dominate the health care field (Rose, 1998) . This can lead to misdiagnosis or under-treatment of heart disease in women. The lack of cardiovascular research for women is evident. The overall research is limited in providing specific evidence for women's cardiovascular health, risk factors, and morbidity.
Further quantitative research is required to support findings and hypotheses highlighted by reviewed studies. Suggestions for future study include women's myocardial infarction symptoms, gender sensitive diagnostic techniques, the role of estrogen, effective management of heart disease, and stress in women. Younger women (i.e., younger than 65 years) present a special area of study.
Qualitative research is needed to study the lived experience of women diagnosed with heart disease. The documented, first hand experience with coronary artery disease could provide the knowledge health care providers need to overcome the cultural and social barriers. For example, women may not feel heart disease is a women's health issue because of the media coverage concerning men's cardiovascular health.
Recently, attention has been focused on the number of women participants in clinical trials for heart disease, because of limited information related to women's heart health (Harris, 2000) . Women are under-enrolled in studies focusing on heart failure. No substantial increase in enrollment in trials for hypertension and arrhythmia has been seen in the past several years. In studies of coronary artery disease, enrolled women equaled or exceeded the affected population proportion. Barriers such as recruitment and retention were not found to be an issue (Harris, 2000) . This leads to the question of why women are not adequately represented in certain trials. Ensuring adequate enrollment in all areas of cardiovascular health will facilitate research applicable to women.
APPLICATION AND MANAGEMENT
Application of the findings from the literature involves educating clients in the workplace about health OCTOBER 2002, VOL. 50, NO. 10 promotion, identifying pertinent risk factors, assessing clients for gender specific symptoms, and providing gender specific management. Health promotion is essential for all women in slowing heart disease mortality. Identification of women at risk is the second step toward decreasing the morbidity and mortality rates. Realizing gender differences in cardiovascular disease allows occupational health professionals to more effectively educate and provide treatment for women.
Health Promotion
Ideally, the management goal is to prevent the onset of coronary artery disease with health promotion interventions. Primary prevention of coronary disease involves education of risk factors and healthy lifestyle practices to reduce risk and alter any present risks to prevent a heart attack or myocardial infarction (American Heart Association, 1999a). Targeted areas for health include a healthy diet, moderate exercise, smoking abstinence, and psychosocial health promotion. Occupational health nurses and occupational health nurse practitioners are in key positions to influence and educate women concerning health behaviors and to produce essential research to combat heart disease (Baer, 1999) .
Identifying Risk Factors
Extensive assessment is required when a woman exhibits heart disease risk factors. Individual risk factor management must be considered before the onset of coronary artery disease because the first cardiovascular event is often fatal in women (Mosca, 1999) . Diabetes, estrogen loss, and psychosocial issues are highlighted from the review.
Diabetes mellitus is a major risk factor for cardiovascular disease. Diabetes and associated hyperglycemia may block the protective effects of estrogen through factors such as increased platelet aggregations and lipoprotein abnormalities (Sowers, 1998) . Diabetes is often associated with high triglyceride levels, hypertension, elevated low density lipoprotein (LDL) cholesterol, and depressed HDL cholesterol. The risk of heart disease is three times higher for women with diabetes than for women without diabetes or men (Hahn, 1998) .
Management of diabetes with emphasis on risk factors, such as high blood pressure and abnormal lipid levels is recommended. All women diagnosed with diabetes mellitus must be regularly screened for cardiovascular disease risk factors. Monitoring of glucose and glycated hemoglobin should be included in the routine evaluation. Women at risk for diabetes (e.g., obesity, family history) should be screened regularly with a fasting glucose (Mosca, 1999) . The maintenance goal of fasting blood glucose is < 110 mg/dL and < 140 mg/dL postprandial (Matfin, 2002) . When indicated, pharmocotherapy with oral agents or insulin should be used to maintain appropriate glucose levels along with continued lifestyle modification (Mosca, 1999) .
Managing abnormal lipid levels and hypertension to reduce complications of diabetes and preventing the onset of heart disease involves promoting a healthier lifestyle with diet, exercise, and weight management. Lipid levels and blood pressure need to be included with the annual health visit (American Heart Association, 1999a). The Adult Treatment Panel (ATP III) guidelines consider multiple factors (e.g., lipoprotein panel, major risk factors, 10 year gender specific risk) when treating hyperlipidemia (National Institutes of Health [NIH], 2001) .
The optimal level for LDL is less than 100 mg/dL. Total cholesterol is recommended less than 200 mg/dL and triglycerides less than 150 mg/dL is desirable. The HDL level of greater than 60 mg/dL is considered ideal. Blood pressure readings are recommended to be less than 130/85 mmHg (NIH, 2001) .
The American Diabetes Association recommends approximately 10% to 20% of daily caloric intake from protein, less than 30% total fat, less than 10% saturated fat, and less than 300 mg cholesterol daily. Carbohydrates vary according to individual eating habits and glucose and lipid goals (American Diabetes Association, 2000) . The use of sodium «2,400 mg per day) and alcohol « 1 drink per day) should be limited. Daily recommendations may be altered because of present risks. Calories may also be reduced to promote weight loss. Women are encouraged to maintain a body mass index (BMI) at 21 to 25 kg/m? (American Heart Association, 1999a).
All able women should participate in some form of physical exercise. However, the activity must be individually designed for a woman's present health status. Medically supervised programs are recommended for women who have had recent heart surgery or heart attacks (Mosca, 1999) .
After a 3 month trial of lifestyle modifications, pharmocotherapy along with lifestyle changes must be initiated to reduce blood pressure and lipid levels. Drug selection varies according to triglyceride, LDL and HDL levels, and blood pressure reading after lifestyle modifications as well as comorbidities. Low density lipoprotein cholesterol lowering drugs and niacin are individually recommended if triglycerides are less than 500 mgldL. For triglycerides greater than 500 mg/dL and elevated LDL levels, a combined drug therapy of niacin, LDL lowering medications, or fibrates, may be considered (NIH, 2001) .
Women's risk for coronary artery disease increases after the onset of menopause. The decreasing production of estrogen has been noted to be responsible for the atherosclerotic changes in the blood vessels (Finking, 1999) . Recent research indicates "postmenopausal hormone replacement therapy should not be used to reduce risk for coronary heart disease (CHD) events in women with CHD" (Grady, 2002) . Each case needs to be evaluated to determine the individual's risks and benefits. No recommendations have been made concerning the use of soy in the prevention of heart disease in postmenopausal women (Alexander, 2001) . Hormone replacement therapy should not be initiated in postmenopausal women for the purpose of secondary prevention of heart disease. All postmenopausal women should be counseled about the risks and benefits of hormone replacement therapy, particularly women with multiple coronary risk factors (American Heart Association, 1999b) .
Individualized management of menopause is recommended according to a woman's risk of developing cardiovascular disease, breast or endometrial cancer, and other risk factors. More research concerning the risks and benefits is required. All necessary points cannot be addressed in this review.
Psychosocial factors can indirectly affect a woman's cardiovascular health. Stressful situations and response to stress must be screened. Support systems, home and job responsibilities, socioeconomic status, and educational level are critical areas to examine. The ultimate goal of management is to adapt to stressful situations in positive ways and improve quality of life (Mosca, 1999) .
Positive coping mechanisms must be encouraged. For example, physical activity can replace smoking. Education related to health promotion and maintenance of health is essential. Identifying social groups or groups with similar health concerns can help establish connections needed for socially isolated women. Educational programs based on socioeconomic need and designed to meet all educational levels need to be established for women with cardiovascular disease. Treatment for depression and anxiety may need to be considered especially for women who have experienced disabling heart problems (Mosca, 1999) .
Presentation Management
Women's heart disease symptoms can be more subtle than men's symptoms. This may lead the health care provider to explore other possible causes rather than heart disease. It is important to remember a client may present with chief symptoms other than chest pain when experiencing cardiac ischemia. Symptoms such as shortness of breath, abdominal pain, and extreme fatigue, or symptoms suggestive of congestive failure may be the only chief symptom (Pope, 2000) .
Careful assessment of recent clinical changes in chest pain and other significant symptoms is needed. This requires obtaining an indepth description of the pain or other chief factors (e.g., onset, duration, location, radiation, aggravating factors). Identification of cardiovascular disease risk factors is essential knowledge to determine the likelihood of disease development (Rose, 1998) .
When a female client has several heart disease risk factors and atypical symptoms, coronary artery disease must not be ruled out. Referral to a specialist is required. By addressing clinical factors or preconceived beliefs about heart disease that may block its diagnosis, the health care provider can more accurately manage heart disease in women.
Gender differences found in diagnostic techniques for coronary artery disease, ECG, stress test, and cardiac catheterization can also contribute to the misdiagnosis of coronary artery disease and myocardial infarction in women. This leads to the question of whether more advanced diagnostic techniques are needed, or if the older techniques are misread or under-read. Management for women at this stage of diagnosis must be based on individual cases, and referral to a specialist is necessary.
Women with or at risk for heart disease must be educated so they do not delay seeking help from a health care provider. Providing education about the disease process, risk factors, and symptoms is an important part of management. The more women are aware of their risk and of gender specific symptoms, the more likely it is they will be alert to their need to seek appropriate health care.
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